Stay updated on Psilocybin Effects in Depressed Patients: Clinical Trial
Sign up to get notified when there's something new on the Psilocybin Effects in Depressed Patients: Clinical Trial page.

Latest updates to the Psilocybin Effects in Depressed Patients: Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedSite revision updated to v3.5.2, replacing the previous v3.5.0 revision.SummaryDifference0.1%

- Check17 days agoNo Change Detected
- Check39 days agoChange DetectedRevision metadata updated: added v3.5.0 and removed v3.4.3. This is a technical metadata change and does not affect content or functionality.SummaryDifference0.1%

- Check46 days agoChange DetectedPage revision updated from v3.4.2 to v3.4.3.SummaryDifference0.1%

- Check74 days agoChange DetectedNew Revision: v3.4.2 is now shown and an older funding notice was removed, reflecting minor maintenance updates with no impact on trial data. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check81 days agoChange DetectedA global site notice about potential information delays due to a lapse in government funding has been added, stating the NIH Clinical Center is open and directing users to opm.gov for updates; the page also shows a new revision label, v3.4.1, replacing 3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check89 days agoChange DetectedExpanded the study record with additional metadata and MeSH terms (e.g., psilocybin, 5HT-2A, IPD) and removed No FEAR Act data.SummaryDifference48%

Stay in the know with updates to Psilocybin Effects in Depressed Patients: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Psilocybin Effects in Depressed Patients: Clinical Trial page.